EPAX Cetoleic 2040 reduces LDL-cholesterol in overweight adults, clinical trial finds

EPAX Cetoleic 2040 reduces LDL-cholesterol in overweight adults, clinical trial finds

PRESS RELEASE

Latest stories

Epax launches first commercially available VLC-PUFA product

Epax launches first commercially available VLC-PUFA product

GRAS- and non-novel food-approved EPAX® Evolve 05 will debut at Vitafoods Europe

Epax boosts innovation and sustainability drive with $10 million investment

Epax boosts innovation and sustainability drive with $10 million investment

Study indicates benefits of EPAX 4020TGN for muscle function and recovery

Study indicates benefits of EPAX 4020TGN for muscle function and recovery

Epax slashes carbon emissions as it transitions to renewables

Epax slashes carbon emissions as it transitions to renewables

Omega dream team: Epax launches first concentrated oil to combine LC-MUFAs and LC-PUFAs

Omega dream team: Epax launches first concentrated oil to combine LC-MUFAs and LC-PUFAs

Epax close to 100% circularity for marine biomaterials

Epax close to 100% circularity for marine biomaterials

Next-level distillation technology creates new opportunities for ultra-concentrated Omega-3

Next-level distillation technology creates new opportunities for ultra-concentrated Omega-3

Beyond Omega-3: Epax launches Omega-11 cetoleic acid

Beyond Omega-3: Epax launches Omega-11 cetoleic acid

PRESS RELEASE

PRESS RELEASE

Epax Norway AS receives funding to explore new marine fatty acids

PRESS RELEASE

PRESS RELEASE

Epax to invest $35 million in Omega-3 innovation

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About Epax

About Epax Norway AS
Epax Norway AS is a leading developer and supplier of high-quality marine lipid concentrates. Since the early beginning in 1838, EPAX® has pioneered innovations in long-chain fatty acids, combining rigorous science, responsible sourcing and advanced process technology. For more information, visit epax.com and follow Epax on LinkedIn.